| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.339 | 6.108 | 10.909 | 13.476 | 16.684 |
| Total Income - EUR | - | - | - | - | - | 2.339 | 6.108 | 10.909 | 13.476 | 16.684 |
| Total Expenses - EUR | - | - | - | - | - | 114 | 709 | 4.150 | 7.522 | 8.584 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.226 | 5.400 | 6.759 | 5.954 | 8.100 |
| Net Profit/Loss - EUR | - | - | - | - | - | 2.155 | 5.217 | 6.432 | 4.207 | 6.836 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Oncovlad S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 20.636 | 14.832 | 9.040 |
| Current Assets | - | - | - | - | - | 2.286 | 7.548 | 5.064 | 15.897 | 28.858 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 1.167 | 1.434 | 3.371 | 1.702 | 3.201 |
| Cash | - | - | - | - | - | 1.120 | 6.114 | 1.693 | 14.195 | 25.657 |
| Shareholders Funds | - | - | - | - | - | 2.197 | 7.364 | 13.819 | 17.983 | 24.718 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 90 | 183 | 11.882 | 12.746 | 13.179 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncovlad S.r.l.